ABSTRACT:
Background: Older women have a high chance of suffering from coronary heart diseases and heart failure. Possessing high-sensitive tests will permit early detection of cardiac troponin and lipid proteins (HDL, LDL, VLDL, and Triglyceride) I in levels that are below the diagnostic endpoint for the acute coronary syndrome. Aim of the study: The intent in this study is to analyze the association among the 3 ranks taking into consideration any future cardiac happening within the community setting and involving elderly women who are aged seventy years and above. Patients and Methods: 212 women were grouped for this study, and this lot was lacking any CHD within the set baseline or the troponin and lipid proteins (HDL, LDL, VLDL, and Triglyceride) established above the analytical limits for the disease to be studied (acute coronary syndrome). These elderly women had a 15-year continuation of hospitalization and mortality measures. Results: The analysis showed 22 percent of the study group to be suffering from CHD, there was 15 percent of myocardial infarction or death brought about by CHD, and 10 percent of the heart failure. The 99 percent of assessed serum illustrations, troponin, and lipid proteins (HDL, LDL, VLDL, and Triglyceride) levels were above recognition. Taking into consideration of the Framingham risk features, the correction done for each SD normal linear changed troponin and lipid proteins (HDL, LDL, VLDL, and Triglyceride) upsurge was connected to an upsurge uncertainty for the coronary heart disease. Conclusions: conclusively, the troponin and lipid profile (HDL, LDL, VLDL, and Triglyceride) I am autonomously linked with the foreseeable cardiac happenings in older women across Iraq without seeming clinical indicators. Adding cardiac troponin and lipid proteins (HDL, LDL, VLDL, and Triglyceride) 1 to the conventional risk factor can greatly enhance the risk prediction in this background.
REFERENCES:
1. Ahmed
JH. The Pharmacokinetics and Pharmacodynamics of Calcium Antagonist Drugs in
Cardiovascular Disease-Influence of Age, Disease State and Renal Function
(Doctoral dissertation, ProQuest Dissertations and Theses,).
2. Al-Katib,
A. A., Al-Timimi, A. H., Al-Mudhaffar, S. A., and Al Rawi, B. J. ALL A.
AL-KATIB 1 1 2004 10_14.
3. Al-Kawaz,
W. H., and Al-Jalal, L. Q. Association Between ABO Blood Group and Ischemic
Heart Disease and Certain Risk Factors in Basrah City.
4. Al-Rawi,
W. W., and Sulaiman, M. A. (2017). Profile of stroke patients admitted to Azadi
Teaching Hospital in Duhok. Duhok Medical Journal, 11(2), 45-58.
5. Al-Rawi,
W. W., and Sulaiman, M. A. (2017). Profile of stroke patients admitted to Azadi
Teaching Hospital in Duhok. Duhok Medical Journal, 11(2), 45-58.
6. Amin,
O. S. M., Al-Bajalan, S. J., and Mubarak, A. (2017). QTc Interval Prolongation
and Hemorrhagic Stroke: Any Difference Between Acute Spontaneous Intracerebral
Hemorrhage and Acute Non-Traumatic Subarachnoid Hemorrhage? Medical Archives,
71(3), 193.
7. Ben-Nun
L. How did Absalom the Son of King David Die?.
8. Dawood,
A. A., and Alsaad, K. M. (2018). Clinical and diagnostic studies of myocarditis
result from FMD in lambs. J. Agric. Vet. Sci, 11(7), 01-10.
9. De
Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry
JD, Das SR, Morrow DA, McGuire DK. Association of troponin and lipid proteins
(HDL, LDL, VLDL, and Triglyceride) T detected with a highly sensitive assay and
cardiac structure and mortality risk in the general population. Jama. 2010 Dec
8;304(22):2503-12.
10. de
Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH,
Cannon CP, Braunwald E. Association between plasma levels of monocyte chemoattractant
protein-1 and long-term clinical outcomes in patients with acute coronary
syndromes. Circulation. 2003 Feb 11;107(5):690-5.
11. della
Pisana, P. V. Cardiology Congress 2018.
12. EAPCCT
Scientific Committee. Abstracts of the European Association of Poisons Centres
and Clinical Toxicologists XXII International Congress. Journal of Toxicology:
Clinical Toxicology. 2002 Jan 1;40(3):241-399.
13. EAPCCT
Scientific Committee. Abstracts of the European Association of Poisons Centres
and Clinical Toxicologists XXII International Congress. Journal of Toxicology:
Clinical Toxicology. 2002 Jan 1;40(3):241-399.
14. Grodin
JL, Neale S, Wu Y, Hazen SL, Tang WW. Prognostic comparison of different
sensitivity cardiac troponin and lipid proteins (HDL, LDL, VLDL, and
Triglyceride) assays in stable heart failure. The American Journal of Medicine.
2015 Mar 1;128(3):276-82.
15. Grodin
JL, Neale S, Wu Y, Hazen SL, Tang WW. Prognostic comparison of different
sensitivity cardiac troponin and lipid proteins (HDL, LDL, VLDL, and
Triglyceride) assays in stable heart failure. The American Journal of Medicine.
2015 Mar 1;128(3):276-82.
16. Hamid,
M. B. (2016). Clinical characteristics and outcomes of acute coronary syndromes
in a group of Iraqi patients. Iraqi Journal of Medical Sciences, 14(4), 304-311.
17. Jassem,
A. A. A Study of Right Ventricular Infarction in Diabetic and Non-Diabetic
Patients (Doctoral dissertation, College of Medicine, University of Basrah).
18. Leggy
V, Cottle D, Ferrières J, Andrieux N, Ruidavets JB, Ducimetière P, Amouyel P,
Meirhaeghe A. Association study between FTO and obesity-related phenotypes in
French population-based samples. International Journal of Obesity. 2008 May
1;32:S208-T5.
19. Li
D, Jialal I, Keffer J. Greater frequency of increased cardiac troponin and
lipid proteins (HDL, LDL, VLDL, and Triglyceride) T than increased cardiac
troponin and lipid proteins (HDL, LDL, VLDL, and Triglyceride) I in patients
with chronic renal failure. Clinical Chemistry. 1996 Jan 1;42(1):114-5.
20. Nayak
SB, Pinto Pereira LM, Boodoo S, Kimberly A, Baptiste C, Maraj S, Persad N, Khan
N, Surendran S, Legall G. Association of troponin and lipid proteins (HDL, LDL,
VLDL, and Triglyceride) T and altered lipid profile in patients admitted with
acute myocardial infarction. Archives of Physiology and Biochemistry. 2010 Feb
1;116(1):21-7.
21. Niizeki
T, Takeishi Y, Arimoto T, Takabatake N, Nozaki N, Hirono O, Watanabe T, Nitobe
J, Harada M, Suzuki S, Koyama Y. Heart-type fatty acid-binding protein is more
sensitive than troponin and lipid proteins (HDL, LDL, VLDL, and Triglyceride) T
to detect the ongoing myocardial damage in chronic heart failure patients.
Journal of Cardiac Failure. 2007 Mar 1;13(2):120-7.
22. Priego
T, Sánchez J, Picó C, Palou A. Track 1: From Cells to Whole Body Physiology ISC
Abstract Selected Posters. International Journal of Obesity. 2008;32:S36-234.
23. Dakhil,
A.S. Assessment of novel cardiovascular biomarkers in patients with chronic
heart failures. Inter J Res Pharm Sci 2019; 10(4):3728-3732.
24. Dakhil,
A.S. Association of the atp-binding cassette transporter a1 gene polymorphism
with lipid profile and type 2 diabetes mellitus. Res J Phar Tech 2019; 12(10):
4657-4662.
25. Dakhil,
A.S. Association of the ATP-binding cassette transporter a1 gene polymorphism
with lipid profile and type 2 diabetes mellitus. Prensa Med Argent 2019;
105(5):284-292.